Pocket Program - CROI

CROI 2013 Session 137
c Tuesday, 2:30-4 pm; Hall B2
Session 135–Poster Abstracts
Risk Prediction, Risk Factors, Biomarkers, and
Outcomes
773 The Veterans Aging Cohort Study Index Predicts Mortality
+
Population Starting HAART
I Bebu1 , J Tate2 , O Mesner1 , G Macalino1 , D Rimland1 , A Ganesan1 ,
A Weintrob1 , A Justice2 , and Brian Agan* 1
1Infectious Disease Clin Res Prgm, Uniformed Svcs Univ of the Hlth Sci,
Bethesda, MD, US and 2Yale Univ and the VA Hlthcare System, West
Haven, CT, US
777
of HIV + Adults Receiving Medical Care in the US: Medical
Angela Thompson-Paul*, S Wei, C Mattson, and J Skarbinski
CDC, Atlanta, GA, US
778 High Prevalence and Severity of Pulmonary Emphysema Is
Giovanni Guaraldi* 1 , G Besutti 1 , R Scaglioni 1 , A Santoro 1 , S Zona 1 ,
E Garlassi 1 , G Ligabue 1 , D Sin 2,3 , J Leipsic 2,3 , and P Man 2,3
1 Modena and Reggio Emilia Univ, Modena, Italy;; 2 British Columbia
Univ, James Hogg Res Ctr, Vancouver, Canada;; and 3 St Pauls Hosp,
Vancouver, Canada
782 Effect of HIV Seroconversion and ART Initiation on Multiple
Kaku Armah* 1 , J Lim 2 , V Lo Re 3 , J Baker 4 , R Tracy 5 , A Butt 2,6 ,
B Agan 7,8 , D Rimland 9,10 , A Justice 11,12 , M Freiberg 2 , and VACS Project Team
1 Univ of Pittsburgh Grad Sch of Publ Hlth, PA, US;; 2 Univ of Pittsburgh
Sch of Med, PA, US;; 3 Univ of Pennsylvania Sch of Med, Philadelphia,
US;; 4 Univ of Minnesota Med Sch, Minneapolis, US;; 5 Univ of Vermont,
Burlington, US;; 6 Sheikh Khalifa Med City, Abu Dhabi, United Arab
Emirates;; 7 Infectious Disease Clin Res Prgm, Bethesda, MD, US;;
8 Uniformed Svs Univ of the Hlth Sci, Bethesda, MD, US;; 9 Emory Univ
Sch of Med, Atlanta, GA, US;; 10 VAMC, Atlanta, GA, US;; 11 VA Connecticut
Hlth Care System and Med Ctr, West Haven, CT, US;; and 12 Yale Univ Sch
of Med, New Haven, CT, US
c Wednesday, 2:30-4 pm; Hall B2
Session 136–Poster Abstracts
Microbial Translocation Measurement and
Associations
783
May Underestimate Lipopolysaccharide Levels in Those with
Helen Byakwaga* 1,2 , P Hsue 2 , E Sambrano 2 , E Sinclair 2 , Y Huang 2 ,
R Tracy 3 , T Burdo 4 , J Martin 2 , C Grunfeld 2 , and P Hunt 2
1 Mbarara Univ of Sci and Tech, Uganda;; 2 Univ of California, San Francisco,
US;; 3 Univ of Vermont, Burlington, US;; and 4 Boston Coll, MA, US
774
HIV + Patients and HIV Stefan Esser* 1 , T Neumann1 , B Bokhof2 , L Eisele2 , B Schwarz1 ,
V Holzendorf3 , R Erbel1 , K-H Joeckel2 , D Schadendorf1 , N Reinsch1 ,
and HIV-HEART Study Group and Heinz Nixdorf Recall Study Group
1 2 Univ Hosp Essen, Germany;; Inst for Med Informatics, Biometry and
Epidemiology, Univ Hosp Essen, Germany;; and 3Univ of Leipzig, Clin
Trial Ctr, Germany
775 Cigarette Smoking among HIV + Adults in Care: Medical
Rennatus Mdodo*, E Frazier, C Mattson, M Sutton, J Brooks,
and J Skarbinski
CDC, Atlanta, GA, US
776
Large HIV + Cohort: Mildmay Uganda Cohort
Farrah Mateen* 1 , S Kanters2 , A Funk3 , E Kyegonza3 , and E Mills4 1 2 Johns Hopkins Univ, Baltimore, MD, US;; Univ of British Columbia,
Vancouver, Canada;; 3Mildmay Uganda, Kampala;; and 4 784
Translocation and Inflammation in Chronic HIV Infection
Gretchen Volpe*
Univ of Ottawa,
Canada
1,2 , C Duffalo1 , D Dinh1 , S Bhalchandra1 , M Mwamburi2 ,
A Kane1,2 , H Ward1,2 , and C Wanke1,2 1 2 Tufts Med Ctr, Boston, MA, US and Tufts Univ, Boston, MA, US
785
Cellular Immune Activation Biomarkers and HAART
Outcomes in Resource-limited Settings
A Balagopal1 , D Asmuth2 , L Smeaton3 , N Gupte1 , V Franco1 , J Hakim4 ,
R Pollard2 , T Campbell5 , D Thomas1 , Amita Gupta* 1 , for ACTG5175
and NWCS319 Study Group
1 2 Johns Hopkins Univ, Baltimore, MD, US;; Univ of California, Davis,
Sacramento, US;; 3Harvard Sch of Publ Hlth, Boston, MA, US;; 4Univ of
Zimbabwe, Harare;; and 5Univ of Colorado Denver, US
786 Asymmetric and Symmetric Dimethylarginine Are
+
Individuals
I Manner1 , M Baekken1 , I Os1,2 , O Oektedalen1 , D Kvale1,2 , I Seljeflot1,2 ,
and Marius Troseid* 1
1 2 Oslo Univ Hosp, Norway and Univ of Oslo, Norway
Program 53
Poster Listings
787
Non-infectious Diarrhea in HIV + Individuals: Results from
Rodger MacArthur* 1 , T Hawkins 2 , S Brown 3 , A LaMarca 4 , P Golden 5 ,
R Rolleri 5 , E Bortey 5 , C Paterson 5 , and W Forbes 5
1 Wayne State Univ, Detroit, MI, US;; 2 Southwest CARE, Santa Fe, NM,
US;; 3 AIDS Res Alliance, Los Angeles, CA, US;; 4 Therafirst Med Ctr, Ft
Lauderdale, FL, US;; and 5 Salix Pharmaceuticals, Inc, Raleigh, NC, US
779
Disease Risk in HIV: A Balance of Pro-Inflammatory and
Allison Ross Eckard* 1 , C Longenecker2,3 , Y Jiang2 , S Debanne2 ,
D Labbato2,3 , N Storer2,3 , and G McComsey2,3 1 2 3 Case Western Reserve Univ, Cleveland, OH, US;; and Univ Hosp Case
Med Ctr, Cleveland, OH, US
780
of All-cause Mortality among Adults Receiving cART in
Botswana: Results from a Clinical Trial
Bethan McDonald* 1,2 , S Moyo2 , L Gabaitiri3 , S Gaseitsiwe1,2 ,
H Bussmann2 , J Koethe4 , J Makhema2 , R Marlink1,2 , W Wester2,4 ,
and M Essex1,2 1 2 Harvard Sch of Publ Hlth, Boston, MA, US;; Botswana-Harvard
AIDS Inst Partnership, Gaborone;; 3Univ of Botswana, Gaborone;;
and 4Vanderbilt Univ Sch of Med, Nashville, TN, US
781
Pashtoon Kasi* 1 , A Mohanty1 , S Erqou1 , K McGinnis2 , K Crothers3 ,
K Corey4,5 , R Chung4,5 , M Freiberg2 , and A Butt2,6 1 2 Univ of Pittsburgh Med Ctr, PA, US;; Univ of Pittsburgh Sch of Med, PA,
US;; 3Univ of Washington, Seattle, US;; 4Massachusetts Gen Hosp, Boston,
US;; 5Harvard Med Sch, Boston, MA, US;; and 6 c Tuesday, 2:30-4 pm; Hall B2
Session 137–Poster Abstracts
(see Session 49 on Wednesday for corresponding Themed Discussion)
Inflammatory Biomarkers, Microparticles,
and Clinical Outcomes in HIV
788 Inflammatory Cytokines and Mortality in a Cohort of HIV
Sheikh Khalifa Med City,
Abu Dhabi, United Arab Emirates
+
Daniel Fuster* 1 , D Cheng1,2 , E Quinn3 , K Armah4 , R Saitz1 ,
M Freiberg5 , J Samet1 , and J Tsui1 1 2 Boston Med Ctr and Boston Univ Sch of Med, MA, US;; Boston Univ Sch
of Publ Hlth, MA, US;; 3Data Coordinating Ctr, Boston Univ Sch of Publ
Hlth, MA, US;; 4Univ of Pittsburgh Grad Sch of Publ Hlth, PA, US;; and
5Univ of Pittsburgh, PA, US
+ 789
Persons Are Reduced
with ART and Associated with D-dimer Levels after Treatment
Jason Baker* 1,2 , K Huppler Hulsiek1 , R Bradford3 , R Prosser1,2 , R Tracy4 ,
and N Key3 1 2 Univ of Minnesota, Minneapolis, US;; Hennepin County Med Ctr,
Minneapolis, MN, US;; 3Univ of North Carolina at Chapel Hill, US;;
and 4Univ of Vermont, Burlington, US
790
Suppressive ART
Allan Tenorio* 1 , E Zheng2 , R Bosch2 , S Deeks3 , B Rodriguez4 , S
Krishnan2 , P Hunt3 , C Wilson5 , M Lederman4 , A Landay1 , and ACTG
1 2 Rush Univ Med Ctr, Chicago, IL, US;; Harvard Sch of Publ Hlth,
Boston, MA, US;; 3San Francisco Gen Hosp and Univ of California, San
Francisco, US;; 4Case Western Reserve Univ Sch of Med, Cleveland, OH,
US;; and 5Univ of Colorado Hosp, Aurora, US
791 Inflammation and Coagulation Markers Are Predictive of
Anemia in ARV-treated HIV Disease
Alvaro Borges* 1 , J Weitz 2 , G Collins 3 , J Baker 3,4 , Y Levy 5 , R Davey 6 ,
A Phillips 7 , J Neaton 3 , J Lundgren 1 , S Deeks 8 , for INSIGHT SILCAAT
Study Group
1 Copenhagen HIV Prgm and Rigshospitalet, Denmark;; 2 Thrombosis
and Atherosclerosis Res Inst, Hamilton, Canada;; 3 Univ of Minnesota,
Minneapolis, US;; 4 Hennepin County Med Ctr, Minneapolis, MN, US;;
5 Assistance Publ-Hosp de Paris, INSERM U955, Univ Paris 12, Creteil,
France;; 6 NIAID, NIH, Bethesda, MD, US;; 7 Univ Coll London Med Sch,
UK;; and 8 Univ of California, San Francisco, US